IMPACT Therapeutics

Public

—N/Ahttps://www.impacttherapeutics.com/

Last Round

IPO Announced

Mar 27, 2026

Total Funding Raised

$169.7M

Company Overview

IMPACT Therapeutics is a biotechnology company that develops synthetic lethality-based precision anti-cancer therapies.

AI Layer

Non-AI

Keywords

oncology therapeuticssynthetic lethalitytargeted cancer therapyDNA damage responseDDRPARP inhibitorsmall-molecule drugprecision medicinedrug discoverybiotechWEE1 inhibitorDHODH inhibitorclinical-stage biotechcancer drug pipelinepharma licensing

IMPACT Therapeutics Comps

Public and private peers based on sector, stage, and business model.

IMPACT Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

IMPACT Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Mar 27, 2026
Series D Extension	Nov 15, 2024
Series D Extension	Apr 22, 2024
Series D	Mar 14, 2022
Series C Extension	Nov 30, 2020
Series C	Aug 3, 2018

View all Funding Rounds

IMPACT Therapeutics Investors

Notable investors and investment history

IMPACT Therapeutics investors
Investor	Rounds
Dingxin Capital	Series D
Xiamen C&D Emerging Industry Equity Investment	Series D Extension
Exome Asset Management	Series D
Lilly Asia Ventures	Series D, Series D Extension, Series C Extension, Series C
Decheng Capital	Series C

View all Investors

IMPACT Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IMPACT Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range5

Year Founded2009

Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.